Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study

By sjmartinez • May 9, 2024

Dacic S, Travis WD, Giltnane JM, Kos F, Abel J, Hilz S, Fujimoto J, Sholl L, Ritter J, Khalil F, Liu Y, Taylor-Weiner A, Resnick M, Yu H, Hirsch FR, Bunn PA Jr, Carbone DP, Rusch V, Kwiatkowski DJ, Johnson BE, Lee JM, Hennek SR, Wapinski I, Nicholas A, Johnson A, Schulze K, Kris MG, Wistuba II. Artificial Intelligence-Powered Assessment of Pathologic Response to Neoadjuvant Atezolizumab in Patients With NSCLC: Results From the LCMC3 Study. J Thorac Oncol. 2024 May;19(5):719-731. doi: 10.1016/j.jtho.2023.12.010. Epub 2023 Dec 7. PMID: 38070597.

Tags: Artificial intelligence, Convolutional neural network, digital pathology, neoadjuvant, NSCLC, Publications, Pulmonary, Critical Care & Sleep Medicine

Ambient AI Scribes in Clinical Practice: A Randomized Trial

Lukac PJ, Turner W, Vangala S, Chin AT, Khalili J, Shih YT, Sarkisian C, Cheng EM, Mafi JN. Ambient AI Scribes in Clinical Practice: A[...]

North American and European practices for opioid-sparing and opioid-free anaesthesia: a cross-sectional survey

Gricourt Y, Boulos NM, Daoulas Y, Grogan T, Alexander B, Mezzarobba M, Cuvillon P, Pogatzki-Zahn EM, Beloeil H, Cannesson M, Forget P, Joosten A. North[...]

Amara Yad Image: The 3-Chamber View-Inferomedial Segment

Shivkumar K, Mori S. Amara Yad Image: The 3-Chamber View-Inferomedial Segment. J Am Coll Cardiol. 2026 Jan 6;87(1):117-119. doi: 10.1016/j.jacc.2025.10.037. PMID: 41498475.